Award

CA204726

Funder: National Cancer Institute

Funded outputs count: 12

Funder award ID: CA204726

OpenAlex ID: G95646643

Prognostic Clinical and Radiographic Biomarkers for BRAF-Targeted Therapy in Advanced Melanoma

2020 · Kaustav P. Shah, Haocan Song, et al. · The Oncologist · 3

Balancing Cancer Immunotherapy Efficacy and Toxicity

2020 · Douglas B. Johnson, Baruch D. Jakubovic, et al. · The Journal of Allergy and Clinical Immunology In Practice · 42

Health care utilization and steroid‐refractory toxicities from immune checkpoint inhibitors

2019 · Laura X. Wang, Henry T. Quach, et al. · Cancer · 24

Empiric Therapy with BRAF and MEK Inhibitors in Metastatic Melanoma

2019 · Christopher G. Cann, Benjamin F. Tillman, et al. · The Oncologist · 1

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

2019 · Douglas B. Johnson, Ali Manouchehri, et al. · Journal for ImmunoTherapy of Cancer · 368

Severe Epididymo-Orchitis and Encephalitis Complicating Anti-PD-1 Therapy

2019 · Henry T. Quach, Charles J. Robbins, et al. · The Oncologist · 52

Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti‐PD‐1 antibodies

2019 · Ines Pires da Silva, Isabella C. Glitza, et al. · Pigment Cell & Melanoma Research · 34

Response to Anti–PD-1 in Uveal Melanoma Without High-Volume Liver Metastasis

2019 · Douglas B. Johnson, Riyue Bao, et al. · Journal of the National Comprehensive Cancer Network · 70

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

2018 · Daniel Y. Wang, Joe-Elie Salem, et al. · JAMA Oncology · 2,678

Faculty Opinions recommendation of Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.

2018 · Jun J Yang, Heng Xu · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

Biomarkers for immune therapy in melanoma

2018 · Douglas Johnson, Jeewon Chon, et al. · Seminars in Cutaneous Medicine and Surgery · 2

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

2017 · Shona Hendry, Roberto Salgado, et al. · Advances in Anatomic Pathology · 806